[1]
|
Keeling, D., Mackie, I., Moore, G.W., Greer, I. and Greaves, M., British Committee for Standards in Haematology (2012) Guidelines on the Investigation and Management of Antiphospholipid Syndrome. British Journal of Haematology, 157, 47-58. http://dx.doi.org/10.1111/j.1365-2141.2012.09037.x
|
[2]
|
Stam, J. (2005) Thrombosis of the Cerebral Veins and Sinuses. New England Journal of Medicine, 352, 1791-1798.
http://dx.doi.org/10.1056/NEJMra042354
|
[3]
|
Galli, M., Luciani, D., Bertolini, G. and Barbui, T. (2003) Lupus Anticoagulants Are Stronger Risk Factors for Thrombosis than Anticardiolipin Antibodies in the Antiphospholipid Syndrome: A Systematic Review of the Literature. Blood, 101, 1827-1832. http://dx.doi.org/10.1182/blood-2002-02-0441
|
[4]
|
Pengo, V., Tripodi, A., Reber, G., Rand, J.H., Ortel, T.L., Galli, M. and De Groot, P.G., Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis (2009) Update of the Guidelines for Lupus Anticoagulant Detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Journal of Thrombosis and Haemostasis, 7, 1737-1740.
http://dx.doi.org/10.1111/j.1538-7836.2009.03555.x
|
[5]
|
Kulkarni, G.B., Mustare, V. and Varghese, V. (2013) Internal Jugular, Subclavian and Brachiocephalic Vein Thrombosis Associated with Cerebral Venous Sinus Thrombosis. Neurology India, 61, 526.
http://dx.doi.org/10.4103/0028-3886.121935
|
[6]
|
Gbaguidi, X., Janvresse, A., Benichou, J., Cailleux, N., Levesque, H. and Marie, I. (2011) Internal Jugular Vein Thrombosis: Outcome and Risk Factors. QJM, 104, 209-219. http://dx.doi.org/10.1093/qjmed/hcq179
|
[7]
|
Bousser, M.G. and Ferro, J.M. (2007) Cerebral Venous Thrombosis: An Update. The Lancet Neurology, 6, 162-170.
http://dx.doi.org/10.1016/S1474-4422(07)70029-7
|
[8]
|
Coutinho, J.M. and Stam, J. (2010) How to Treat Cerebral Venous and Sinus Thrombosis. Journal of Thrombosis and Haemostasis, 8, 877-883. d http://dx.doi.org/10.1111/j.1538-7836.2010.03799.x
|
[9]
|
Cervera, R., Piette, J.C., Font, J., Khamashta, M.A., Shoenfeld, Y., Camps, M.T., et al. (2002) Antiphospholipid Syndrome: Clinical and Immunologic Manifestations and Patterns of Disease Expression in a Cohort of 1,000 Patients. Arthritis & Rheumatism, 46, 1019-1027. http://onlinelibrary.wiley.com/doi/10.1002/art.10187/full
http://dx.doi.org/10.1002/art.10187
|
[10]
|
Saposnik, G., Barinagarrementeria, F., Brown Jr., R.D., Bushnell, C.D., Cucchiara, B., Cushman, M., et al. (2011) Diagnosis and Management of Cerebral Venous Thrombosis: A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke: A Journal of Cerebral Circulation, 42, 1158-1192.
http://stroke.ahajournals.org/content/42/4/1158.long
http://dx.doi.org/10.1161/STR.0b013e31820a8364
|
[11]
|
Cumurciuc, R., Crassard, I., Sarov, M., Valade, D. and Bousser, M. (2005) Headache as the Only Neurological Sign of Cerebral Venous Thrombosis: A Series of 17 Cases. Journal of Neurology, Neurosurgery & Psychiatry, 76, 1084-1087.
http://dx.doi.org/10.1136/jnnp.2004.056275
|
[12]
|
Ferro, J.M., Canhao, P., Stam, J., Bousser, M.G. and Barinagarrementeria, F., for the ISCVT Investigators (2004) Prognosis of Cerebral Vein and Dural Sinus Thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke: A Journal of Cerebral Circulation, 35, 664-670.
http://stroke.ahajournals.org/content/35/3/664.long
http://dx.doi.org/10.1161/01.STR.0000117571.76197.26
|
[13]
|
Leach, J.L., Fortuna, R.B., Jones, B.V. and Gaskill-Shipley, M.F. (2006) Imaging of Cerebral Venous Thrombosis: Current Techniques, Spectrum of Findings, and Diagnostic Pitfalls. Radiographics, 26, 19-41.
http://dx.doi.org/10.1148/rg.26si055174
|
[14]
|
Rand, J., Wu, X., Quinn, A. and Taatjes, D. (2008) Resistance to Annexin A5 Anticoagulant Activity: A Thrombogenic Mechanism for the Antiphospholipid Syndrome. Lupus, 17, 922-930.
http://dx.doi.org/10.1177/0961203308095029
|
[15]
|
Malia, R., Kitchen, S., Greaves, M. and Preston, F. (1990) Inhibition of Activated Protein C and Its Cofactor Protein S by Antiphospholipid Antibodies. British Journal of Haematology, 76, 101-107.
http://dx.doi.org/10.1111/j.1365-2141.1990.tb07843.x
|
[16]
|
Greaves, M. (1999) Antiphospholipid Antibodies and Thrombosis. The Lancet, 353, 1348-1353.
http://www.sciencedirect.com/science/article/pii/S0140673698103628
http://dx.doi.org/10.1016/S0140-6736(98)10362-8
|